Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins

Cancer Immunology Immunotherapy

Volumn 42, Issue 6, 1996, Pages 319-328

  Vooijs, W C ^a   Post, J ^a   Wijdenes, J ^b   Schuurman, H J ^a   Bolognesi, A ^c   Polito, L ^c   Stirpe, F ^c   Bast, E J E G ^a   De Gast, G C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Diaclone   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

B B2; B B4; Immunotoxin; Multiple myeloma; Plasma cell

Indexed keywords

IMMUNOTOXIN; MONOCLONAL ANTIBODY; SAPORIN;

ARTICLE; CANCER IMMUNOTHERAPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ANTIBODIES, MONOCLONAL; BONE MARROW; BONE MARROW CELLS; CELL DIVISION; CELL LINE; ENDOTHELIUM; EPITHELIAL CELLS; EPITHELIUM; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTOXINS; LIVER; MULTIPLE MYELOMA; PLASMA CELLS; SENSITIVITY AND SPECIFICITY;

EID: 0029796186     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050289     Document Type: Article

References (48)

1. Amlot P, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V, Ramilo O, Thorpe PE, Uhr JW, Vitetta ES (1993) A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82:2624
2. Anderson KC, Park EK, Bates MP, Leonard RCF, Hardy R, Schlossman SF, Nadler LM (1983) Antigens on human plasma cells identified by monoclonal antibodies. J Immunol 130:1132
3. Anderson KC, Bates MP, Slaughenhoupt B, Schlossman SF, Nadler LM (1984) A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol 132:3172
4. Anderson KC, Anderson J, Soiffer R, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Blake K, Murray C, Freeman A, Coral F, Marcus KC, Mausch P, Nadler L, Ritz J (1993) Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 82:2568
5. Barbieri L, Stoppa C, Bolognesi A (1987) Large scale chromatographic purification of ribosome-inactivating proteins. J Chromatogr 408:235
6. Barlogie B, Epstein J, Selvanayagam P, Alexanian R (1989) Plasma cell myeloma - New biological insights and advances in therapy. Blood 73:865
7. Bast RC, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz, J (1985) Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 45:499
8. Blakey DC, Wawrzynczak EJ, Wallace PM, Thorpe PE (1988) Antibody toxin conjugates: a perpective. In: Waldmann H (ed) Monoclonal antibody therapy. Karger, Basel, p 50
9. Bolognesi A, Tazzari PL, Legname G, Olivieri F, Modena D, Conte R, Stirpe F (1995) Anti-CD30 immunotoxins with native and recombinant dianthin 30. Cancer Immunol Immunother 40:109
10. Caligaris-Cappio F, Bergui L, Tesio L, Pizzolo G, Malavasi F, Chilosi M, Campana D, van Camp B, Janossy G (1985) Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest 76:1243
11. Carrasquillo JA, Sugarbaker P, Colcher D, Reynolds JC, Esteban J, Bryant G, Keenan AM, Perentesis P, Yokohama K, Simpson DE, Ferroni P, Farkas R, Schlom J, Larson SM (1988) Radioimmunoscintigraphy of colon carcinoma with iodine-131-labeled B72.3 monoclonal antibody. J Nucl Med 29:1022
12. Chatal J-F, Saccavini J-C, Fumoleau P, Douillard J-Y, Curtet C, Kremer M, Le Mevel B, Koprowski H (1984) Immunoscintigraphy of colon carcinoma. J Nucl Med 25:307
13. Clement C, Vooijs WC, Klein B, Wijdenes J (1995) B-B2 and B-B4, two new mAb against secreting plasma cells. In: Schlossman S et al (eds) Proceedings of the Vth International Workshop and Conference on Human Leucocyte Differentiation Antigens. Oxford University Press, Oxford, p 714
14. Cobb LM (1989) Intratumour factors influencing the access of antibody to tumour cells. Cancer Immunol Immunother 28:235
15. Czuczman MS, Straus DJ, Divgi CR, Graham M, Garin-Chesa P, Finn R, Myers J, Old LJ, Larson SM, Scheinberg DA (1993) Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma. J Clin Oncol 11:2021
16. Dinota A, Barbieri L, Gobbi M, Tazzari PL, Rizzi S, Bontadini A, Bolognesi A, Tura S, Stirpe F (1989) An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients. Br J Cancer 60:315
17. Durie BGM (1988) The biology of multiple myeloma. Hematol Oncol 6:77
18. Edwards DC, McIntosh DP (1986) Targeting potential of antibody conjugates. In: Ihler GM (ed) Methods of drug delivery. Pergamon, Oxford, p 83
19. Epstein J, Barlogie B, Katzmann J, Alexanian R (1988) Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 71:861
20. Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Dürkop H, Aversa F, Corneli P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Martelli MF, Stirpe F (1992) Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet 339:1195
21. Gobbi M, Cavo M, Tazzari PL, Dinota A, Tassi C, Bontadini A, Albertazzi L, Miggiano C, Rizzi S, Rosti G, Bolognesi A, Stirpe F, Tura S (1989) Autologous bone marrow transplantation with immunotoxin-purged marrow for advanced multiple myeloma. Eur J Haematol [Suppl 51] 43:176
22. Goldmacher VS, Bourret LA, Levine BA, Rasmussen RA, Pourshadi M, Lambert JA, Anderson KC (1994) Anti-CD38-blocked ricin: An immunotoxin for the treatment of multiple myeloma. Blood 84:3017
23. Gonchoroff NJ, Katzman JA, Garton JP, Ruiz-Argüelles GJ, Eilers CR, Greipp PR, Kyle RA (1986) A monoclonal antibody reactive with a subset of human plasma cells. Br J Haematol 62:619
24. Gould BJ, Borowitz MJ, Groves ES, Carter PW, Anthony D, Weiner LM, Frankel AE (1989) Phase I study of an anti-breast cancer immunotoxin by continuous infusion: report of a targeted toxic effect not predicted by animal studies. J Natl Cancer Inst 81:775
25. Grogan TM, Durie BGM, Lomen C, Spier C, Win DP, Nagle R, Wilson GS, Richter L, Vela E, Maxey V, McDaniel K, Rangel C (1987) Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immuno-phenotypic, genotypic, cytologic, cell culture and kinetic features. Blood 70:932
26. Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM (1992) Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80:863
27. Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blättler WA, Taylor JA, Nadler JM (1992) Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion. Blood 79:576
28. Haagen I-A, Geerars AJG, De Lau WBM, Bast EJEG, De Gast GC (1995) The efficacy of CD3xCD19 BsAb in a clonogenic assay: the effect of repeated addition of bispecific antibody and IL-2. Blood 85:3208
29. Johnson EA, Brown BW (1961) The Spearman estimator for serial dilution assays. Biometrics 17:79
30. Kaminski MS, Zasadny KR, Francis IR, Milik AW, Ross CW, Moon SD, Crawford SM, Burgess JM, Petry NA, Butschko GM, Glenn SD, Wahl RL (1993) Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. N Engl J Med 329:459
31. Lokhorst HM, Boom SE, Bast BJEG, Peters PJ, Tedder TF, Gerdes J, Petersen E, Ballieux RE (1987) Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern. J Clin Invest 79:1401
32. Mendelsohn J (1991) Immunotoxins: prospects and problems. J Clin Oncol 9:2088
33. Pai LH, Bookman MA, Ozols RF, Young RC, Smith II JW, Longo DL, Gould B, Frankel A, McClay EF, Howell S, Reed E, Willingham MC, FitzGerald DJ, Pastan I (1991) Clinical evaluation of intraperitoneal pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol 9:2095
34. Pak KY, Nedelman MA, Fogler WE, Tam SH, Wilson E, van Haarlem LJM, Colognola R, Warnaar SO, Daddona PE (1991) Evaluation of the 323/A3 monoclonal antibody and the use of technetium-99m-labeled 323/A3 Fab′ for the detection of pan adenocarcinoma. Nucl Med Biol 18:483
35. Parente A, De Luca P, Bolognesi A, Barbieri L, Batelli MG, Abbondanza A, Sande MJW, Gigliano GS, Tazzari PL, Stirpe F (1993) Purification and partial characterization of single-chain ribosome inactivating proteins from the seeds of Phytolacca dioica L. Biochim Biophys Acta 1216:43
36. Post J, Vooijs WC, De Gast GC, Bast EJEG (1995) Comparison of various in vitro assays for efficacy screening of immunotoxins. Leuk Res 19:241
37. Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B, Matthews DC, Fisher LD, Bernstein, ID (1993) Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329:1219
38. San Miguel JF, Caballero MD, Gonzalez M, Zola H, Lopez Borrasca A (1986) Immunological phenotype of neoplasms involving the B cell in the last step of differentiation. Br J Haematol 62:75
39. Stirpe F (1988) Antibody-toxin conjugates (immunotoxins) as potential therapeutic agents. Acta Oncol 9:353
40. Tazzari PL, Gobbi M, Dinota A, Bontadini A, Grassi G, Cerato C, Cavo M, Pileri S, Caligaris-Cappio F, Tura S (1987) Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Clin Exp Immunol 70:192
41. + lymphoma: in vitro evaluation. Br J Haematol 81:203
42. Tong AW, Lee FC, Stone MJ (1987) Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells. Blood 69:238
43. Tong AW, Lee J, Wang R-M, Dalton WS, Tsuruo T, Fay JW, Stone MJ (1989) Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody. Cancer Res 49:4829
44. Vallera DA (1994) Immunotoxins: will their clinical promise be fulfilled?. Blood 83:309
45. 99mTc-labeled monoclonal antibody E48 F(ab′)2. Cancer Res 52:2569
46. Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D, Ghetie V, Uhr JW, Thorpe PE (1991) Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res 51:4052
47. Vogel CW (1987) Immunoconjugates: antibody conjugates in radioimaging and therapy of cancer. Oxford University Press, New York
48. Wawrzynczak EJ, Thorpe PE (1986) Monoclonal antibodies and therapy. In: Franks LM, Teich MN (eds) Introduction to the cellular and molecular biology of cancer. Oxford Science Publications, Oxford, p 378